Related Experiment Videos

Sequelae from meningococcal meningitis in children: a critical analysis of dexamethasone therapy

Erasmo Barbante Casella1, Saul Cypel, André Alexandre Osmo

  • 1Pediatric Department of University of São Paulo (USP) Medical School, São Paulo SP, Brasil. erasmobc@icr.hcnet.usp.br

Arquivos De Neuro-Psiquiatria
|July 27, 2004
PubMed

Insights

Dexamethasone did not reduce sequelae in children with meningococcal meningitis. This study found no significant difference in neurological, auditory, or intellectual outcomes between groups receiving dexamethasone and those who did not.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Neurology

Background:

  • Meningococcal meningitis is a severe infection in children.
  • Sequelae can significantly impact long-term health and development.
  • Adjunctive therapies are explored to improve outcomes.

Purpose of the Study:

  • To assess the efficacy of dexamethasone as a supplementary treatment for pediatric meningococcal meningitis.
  • To determine if dexamethasone influences the occurrence of sequelae.

Main Methods:

  • A cohort of 81 children with meningococcal meningitis was divided into four groups based on dexamethasone administration timing relative to antibiotics.
  • Groups included pre-antibiotic, concomitant, post-antibiotic, and no-dexamethasone administration.
  • Patients were evaluated for neurological, auditory, and intellectual sequelae.

Main Results:

  • Overall sequelae occurred in 26.22% of survivors, with no significant difference between the four groups.
  • Neurological alterations were detected in 16.17% of patients, with no statistically significant differences across groups.
  • Hearing loss and intellectual disabilities were observed, but dexamethasone use did not correlate with reduced incidence.

Conclusions:

  • Dexamethasone, as an adjunctive therapy, did not demonstrate effectiveness in reducing the incidence or severity of sequelae in children with meningococcal meningitis.
  • The timing of dexamethasone administration relative to antibiotics did not alter patient outcomes.
  • Further research may be needed to explore other therapeutic strategies.
Abstract

Related Concept Videos

Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...